Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma

Robert A Smith1, Rod A Lea, Stephen R Weinstein

  • 1Genomics Research Centre and Wesley Research Institute, School of Health Science, Griffith University Gold Coast, QLD, Australia.

Cancer Letters
|May 22, 2007
PubMed

Insights

Cancer stroma exhibits altered hormone receptor signaling. Progesterone and glucocorticoid receptor mRNA levels significantly differ in tumor stroma, suggesting potential cancer-stroma crosstalk via hormone signaling pathways.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Previous research indicated elevated anti-mitogenic nuclear receptor mRNA in late-stage tumors.
  • Hormone signaling plays a crucial role in various physiological and pathological processes, including cancer development.

Purpose of the Study:

  • To investigate the potential for cancer-stroma crosstalk mediated by hormone signaling.
  • To examine the expression levels of key nuclear hormone receptors in tumor stromal tissue.

Main Methods:

  • Semi-quantitative PCR was employed to analyze RNA levels of estrogen receptors alpha and beta, androgen receptor, progesterone receptor, and glucocorticoid receptor in stromal tissue.
  • Expression data was compared between cancer stroma and control tissues, considering cancer grade and estrogen receptor status.

Main Results:

  • Significant differences in mRNA expression were observed for progesterone receptor (p=5.908 x 10(-7)) and glucocorticoid receptor (p=2.761 x 10(-5)) between cancer stroma and control tissues.
  • Glucocorticoid receptor mRNA levels were significantly increased in the stroma of estrogen receptor-negative tumors (p=5.85 x 10(-5)).
  • Estrogen receptors alpha and beta, and androgen receptor mRNA levels showed no significant changes in the stroma.

Conclusions:

  • The findings suggest that progesterone and glucocorticoid receptors are involved in cancer-stroma crosstalk.
  • Altered expression of these receptors in the tumor microenvironment may contribute to tumor progression.
  • Estrogen and androgen signaling pathways appear less involved in this specific crosstalk mechanism in the studied tumor stroma.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...